AXS Investments’s Labcorp LH Stock Holding History

AXS Investments’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.03M	Sell	3,862 -162	-4%	-$43.9K	0.42%	57
2025 Q4	$1.01M	Sell	4,024 -161	-4%	-$42.8K	0.35%	73
2025 Q3	$1.2M	Buy	4,185 +125	+3%	+$33.5K	0.38%	69
2025 Q2	$1.07M	Sell	4,060 -2,016	-33%	-$491K	0.44%	79
2025 Q1	$1.41M	Buy	6,076 +1,476	+32%	+$358K	0.39%	95
2024 Q4	$1.05M	Buy	+4,600	New	+$1.06M	0.29%	163
2023 Q2	–	Sell	-361	Closed	-$71.1K	–	455
2023 Q1	$71.1K	Buy	+361	New	+$74.3K	0.02%	280
2021 Q3	–	Sell	-1,852	Closed	-$439K	–	165
2021 Q2	$439K	Buy	+1,852	New	+$422K	0.13%	124

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AXS Investments's LH Position: Q1 2026 in Review

AXS Investments reduced its Labcorp (LH) stake by 4% in Q1 2026, selling an estimated $43.9K and leaving 3,862 shares worth $1.03M. The position accounts for 0.42% of the portfolio, ranked #57.

AXS Investments first reported a position in LH in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.41M in Q1 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

AXS Investments held 3,862 shares of Labcorp worth $1.03M as of Q1 2026.
AXS Investments sold 162 Labcorp shares in Q1 2026, an estimated $43.9K.
Labcorp made up 0.42% of AXS Investments's portfolio in Q1 2026, its #57 holding.
AXS Investments first reported a position in Labcorp in Q2 2021 and has held it in 8 quarters since.
AXS Investments's Labcorp position peaked at $1.41M in Q1 2025.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on AXS Investments's 13F filing for Q1 2026, filed 6 May 2026.